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Abstract 
Background: An advantageous but challenging approach to overcome the limited supply of petroleum and relieve 
the greenhouse effect is to produce bulk chemicals from renewable materials. Fatty alcohols, with a billion-dollar 
global market, are important raw chemicals for detergents, emulsifiers, lubricants, and cosmetics production. Micro-
bial production of fatty alcohols has been successfully achieved in several industrial microorganisms. However, most 
of the achievements were using glucose, an edible sugar, as the carbon source. To produce fatty alcohols in a renew-
able manner, non-edible sugars such as xylose will be a more appropriate feedstock.
Results: In this study, we aim to engineer a Saccharomyces cerevisiae strain that can efficiently convert xylose to fatty 
alcohols. To this end, we first introduced the fungal xylose utilization pathway consisting of xylose reductase (XR), 
xylitol dehydrogenase (XDH), and xylulose kinase (XKS) into a fatty alcohol-producing S. cerevisiae strain (XF3) that 
was developed in our previous studies to achieve 1-hexadecanol production from xylose at 0.4 g/L. We next applied 
promoter engineering on the xylose utilization pathway to optimize the expression levels of XR, XDH, and XKS, 
and increased the 1-hexadecanol titer by 171 %. To further improve the xylose-based fatty alcohol production, two 
optimized S. cerevisiae strains from promoter engineering were evolved with the xylose as the sole carbon source. We 
found that the cell growth rate was improved at the expense of decreased fatty alcohol production, which indicated 
1-hexadecanol was mainly produced as a non-growth associated product. Finally, through fed-batch fermentation, 
we successfully achieved 1-hexadecanol production at over 1.2 g/L using xylose as the sole carbon source, which 
represents the highest titer of xylose-based 1-hexadecanol reported in microbes to date.
Conclusions: A fatty alcohol-producing S. cerevisiae strain was engineered in this study to produce 1-hexadecanol 
from xylose. Although the xylose pathway we developed in this study could be further improved, this proof-of-
concept study, for the first time to our best knowledge, demonstrated that the xylose-based fatty alcohol could be 
produced in S. cerevisiae with potential applications in developing consolidated bioprocessing for producing other 
fatty acid-derived chemicals.
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Background
Producing bulk chemicals from renewable resources 
could reduce strong dependence on petroleum and the 
damage to the environment [1, 2]. As important chemi-
cals with a billion-dollar market globally [3, 4], fatty 
alcohols have been widely used to produce detergents, 
emulsifiers, lubricants, cosmetics, and have the potential 
to be used as fuels [5]. Currently, fatty alcohols are pro-
duced in two ways. One is direct extraction from natural 
plant oils [6], and the other is chemical synthesis from 
petrochemical sources. These methods have limitations 
due to either competition with the food supply, environ-
mental concerns [7], or fast depletion of fossil sources [8].
Recently, with the development of metabolic engi-
neering and synthetic biology, microbial production 
of fatty alcohols from renewable feedstock has been 
achieved successfully in both Escherichia coli [4, 9] and 
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Saccharomyces cerevisiae [3, 10]. So far, the highest titer 
of fatty alcohols produced was 1.95 [11] and 1.1 g/L [10] 
by E. coli and S. cerevisiae respectively. A significantly 
higher titer of fatty alcohols was recently reported to 
be produced by R. toloroides [12]. In E. coli, fatty alco-
hols have been produced by introducing heterologous 
enzymes such as fatty acyl-CoA reductase (FAR) [13], 
carboxylic acid reductase (CAR) [14] together with alde-
hyde reductases (AR), or acyl-CoA reductase (ACR) 
together with AR [4, 15]. Compared to that in E. coli, the 
synthetic route (i.e., steps of enzymatic reactions) of fatty 
acyl-CoA is shorter in yeast, which allows more efficient 
conversion of carbohydrate substrates to fatty acids and 
fatty acid-derived biofuels [9]. Also, as a well character-
ized robust industrial host, yeast can grow under low pH 
and various harsh fermentation conditions [16]. There-
fore, there has been an increasing interest on developing 
yeast, such as S. cerevisiae, as a cell factory for fatty acid-
derived biofuel production. In S. cerevisiae, a mouse 
FAR has been expressed to produce 1-hexadecanol [10]. 
Through over-expression of acetyl-CoA carboxylase 
(ACC) and fatty-acyl-CoA synthases (FAS), the engi-
neered S. cerevisiae strain produced 98.0 mg/L total fatty 
alcohol from 20 g/L glucose in batch culture in minimal 
medium [3]. Recently, by manipulating the structural 
genes in yeast lipid metabolism, tuning the regulation of 
phospholipid synthesis, and increasing the supply of key 
precursors, 1-hexadecanol was produced at 1.1 g/L using 
glucose as the carbon source in a fed-batch fermentation 
[10].
One of the limitations for current research on meta-
bolic engineering to produce fatty acid-derived chemi-
cals is that almost all of the achievements were based on 
glucose as the carbon source. To produce biofuels and 
biochemicals in a renewable manner, non-edible sug-
ars such as xylose will be a more appropriate feedstock. 
Recently, engineering S. cerevisiae to utilize xylose is of 
great interest to the biofuel industry and could solve the 
major bottleneck in complete and efficient conversion of 
cellulosic sugars present in solubilized cell wall of plants 
into biofuels [17]. The sugar d-xylose, derived from 
hydrolysis of hemicellulose, is the second most abundant 
sugar in the plant cell wall consisting of up to 35  % of 
the total carbohydrate from lignocellulose biomass [18]. 
However, since the yeast S. cerevisiae cannot metabolize 
xylose, heterologous xylose utilization pathways need to 
be introduced into S. cerevisiae to achieve this objective. 
Two different pathways for the catabolism of d-xylose 
have been established in S. cerevisiae: the fungal xylose 
pathway consisting of xylose reductase (XR), xylitol dehy-
drogenase (XDH), and xylulose kinase (XKS) [17, 19–21], 
and the xylose pathway using the enzyme, xylose isomer-
ase, to convert d-xylose directly into d-xylulose [22, 23], 
followed by the phosphorylation of d-xylulose to d-xylu-
lose-5-phosphate. Recently, xylose isomerase has been 
successfully used in an industrial yeast strain [24].
In this study, we aim to engineer a S. cerevisiae strain 
that can efficiently convert xylose to fatty alcohols, by 
expressing a heterologous fungal xylose pathway into a 
1-hexadecanol-producing S. cerevisiae strain that has 
been previously developed. We chose a S. cerevisiae 
strain, namely XF3, as our host since it has been engi-
neered to produce 1-hexadecanol at over 1  g/L from 
glucose, and introduced XR, XDH, and XKS into XF3 to 
utilize xylose as the sole carbon source. Then, by apply-
ing combinatorial promoter engineering and evolution-
ary engineering, the production of 1-hexadecanol was 
enhanced by 171  %. Finally, over 1.2  g/L 1-hexadecanol 
was produced in a fed-batch fermentation using xylose as 
the sole carbon source, which is at the similar level when 
using the glucose as the carbon source [10]. To our best 
knowledge, it is the first time that yeast was engineered 
to use a pentose sugar for producing fatty acid-derived 
biofuels.
Methods
Yeast strains, media, and transformation
The yeast strains used in this study were derived from 
BY4742 (Table 1). Yeast and bacterial strains were stored 
in 25 % glycerol at −80 °C. E. coli DH5α strain was used 
to maintain and amplify plasmids, and recombinant 
strains were cultured at 37  °C in Luria–Bertani (LB) 
broth. Ampicillin at 100 μg/mL was added to the medium 
when required. Yeast BY4742 strains were cultivated 
in YPAD medium. Yeast cells were transformed with 
plasmids listed in Table  1 using the LiAc/PEG method 
as described previously [25]. To select the yeast trans-
formants, a synthetic complete (SC) medium was used, 
which contains 0.17 % yeast nitrogen base, 0.5 % ammo-
nium sulfate, and the appropriate amino acids dropout 
mix (MP Biomedicals, Solon, OH). A single colony was 
picked and cultivated in 5  mL SC medium containing 
20 g/L glucose. The cells were cultivated at 30 °C in dis-
posable culture tubes shaken at 250 rpm for 2 days.
Plasmid construction
A yeast homologous recombination-based method, DNA 
assembler [26], was used to construct the recombinant 
plasmids. Briefly, DNA fragments sharing homologous 
regions to adjacent DNA fragments were co-transformed 
into S. cerevisiae along with the linearized backbone to 
assemble several elements in a single step [27]. Oligo-
nucleotides used in this study were listed in Additional 
file 1: Table S1 and the recombinant plasmids constructed 
in this study were listed in Table  1. To construct the 
library for promoter engineering, the csXR was amplified 
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Table 1 Plasmids and strains used in this study
Name Description Reference
Plasmids used in this study
 pTaFAR_ACC1 pRS425-TEF1p-TaFAR-TEF1t-PGK1p-ACC1-HXT7t [36]
 pYlACL pRS423-TPI1p-YlACL1-TPI1t-TEF1p-YlACL2-TEF1t [39]
 pXF3X01 pRS416-PDC1p(L)-csXR-ADH1t-TEF1p(L)-ctXDH-CYC1t-ENO2p(L)-ppXKS-ADH2t This study
 pXF3X02 pRS416-PDC1p(L)-csXR-ADH1t-TEF1p(L)-ctXDH-CYC1t-ENO2p(M)-ppXKS-ADH2t This study
 pXF3X03 pRS416-PDC1p(L)-csXR-ADH1t-TEF1p(L)-ctXDH-CYC1t-ENO2p(H)-ppXKS-ADH2t This study
 pXF3X04 pRS416-PDC1p(L)-csXR-ADH1t-TEF1p(M)-ctXDH-CYC1t-ENO2p(L)-ppXKS-ADH2t This study
 pXF3X05 pRS416-PDC1p(L)-csXR-ADH1t-TEF1p(M)-ctXDH-CYC1t-ENO2p(M)-ppXKS-ADH2t This study
 pXF3X06 pRS416-PDC1p(L)-csXR-ADH1t-TEF1p(M)-ctXDH-CYC1t-ENO2p(H)-ppXKS-ADH2t This study
 pXF3X07 pRS416-PDC1p(L)-csXR-ADH1t-TEF1p(H)-ctXDH-CYC1t-ENO2p(L)-ppXKS-ADH2t This study
 pXF3X08 pRS416-PDC1p(L)-csXR-ADH1t-TEF1p(H)-ctXDH-CYC1t-ENO2p(M)-ppXKS-ADH2t This study
 pXF3X09 pRS416-PDC1p(L)-csXR-ADH1t-TEF1p(H)-ctXDH-CYC1t-ENO2p(H)-ppXKS-ADH2t This study
 pXF3X10 pRS416-PDC1p(M)-csXR-ADH1t-TEF1p(L)-ctXDH-CYC1t-ENO2p(L)-ppXKS-ADH2t This study
 pXF3X11 pRS416-PDC1p(M)-csXR-ADH1t-TEF1p(L)-ctXDH-CYC1t-ENO2p(M)-ppXKS-ADH2t This study
 pXF3X12 pRS416-PDC1p(M)-csXR-ADH1t-TEF1p(L)-ctXDH-CYC1t-ENO2p(H)-ppXKS-ADH2t This study
 pXF3X13 pRS416-PDC1p(M)-csXR-ADH1t-TEF1p(M)-ctXDH-CYC1t-ENO2p(L)-ppXKS-ADH2t This study
 pXF3X14 pRS416-PDC1p(M)-csXR-ADH1t-TEF1p(M)-ctXDH-CYC1t-ENO2p(M)-ppXKS-ADH2t This study
 pXF3X15 pRS416-PDC1p(M)-csXR-ADH1t-TEF1p(M)-ctXDH-CYC1t-ENO2p(H)-ppXKS-ADH2t This study
 pXF3X16 pRS416-PDC1p(M)-csXR-ADH1t-TEF1p(H)-ctXDH-CYC1t-ENO2p(L)-ppXKS-ADH2t This study
 pXF3X17 pRS416-PDC1p(M)-csXR-ADH1t-TEF1p(H)-ctXDH-CYC1t-ENO2p(M)-ppXKS-ADH2t This study
 pXF3X18 pRS416-PDC1p(M)-csXR-ADH1t-TEF1p(H)-ctXDH-CYC1t-ENO2p(H)-ppXKS-ADH2t This study
 pXF3X19 pRS416-PDC1p(H)-csXR-ADH1t-TEF1p(L)-ctXDH-CYC1t-ENO2p(L)-ppXKS-ADH2t This study
 pXF3X20 pRS416-PDC1p(H)-csXR-ADH1t-TEF1p(L)-ctXDH-CYC1t-ENO2p(M)-ppXKS-ADH2t This study
 pXF3X21 pRS416-PDC1p(H)-csXR-ADH1t-TEF1p(L)-ctXDH-CYC1t-ENO2p(H)-ppXKS-ADH2t This study
 pXF3X22 pRS416-PDC1p(H)-csXR-ADH1t-TEF1p(M)-ctXDH-CYC1t-ENO2p(L)-ppXKS-ADH2t This study
 pXF3X23 pRS416-PDC1p(H)-csXR-ADH1t-TEF1p(M)-ctXDH-CYC1t-ENO2p(M)-ppXKS-ADH2t This study
 pXF3X24 pRS416-PDC1p(H)-csXR-ADH1t-TEF1p(M)-ctXDH-CYC1t-ENO2p(H)-ppXKS-ADH2t This study
 pXF3X25 pRS416-PDC1p(H)-csXR-ADH1t-TEF1p(H)-ctXDH-CYC1t-ENO2p(L)-ppXKS-ADH2t This study
 pXF3X26 pRS416-PDC1p(H)-csXR-ADH1t-TEF1p(H)-ctXDH-CYC1t-ENO2p(M)-ppXKS-ADH2t This study
 pXF3X27 pRS416-PDC1p(H)-csXR-ADH1t-TEF1p(H)-ctXDH-CYC1t-ENO2p(H)-ppXKS-ADH2t This study
 pXF3XP pRS416-PDC1p-csXR-ADH1t-TEF1p-ctXDH-CYC1t-ENO2p-ppXKS-ADH2t This study
 pXF3XPi pRS416-PDC1p*-csXR-ADH1t-TEF1p*-ctXDH-CYC1t-ENO2p*-ppXKS-ADH2t [40]
Name Genotype Plasmids Reference
Strains used in this study
 BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0
 XF3 BY4742 ΔRPD3: pTaFAR_ACC1, pYlACL [36]
 XF3XP Same as XF3 pXF3XP This study
 XF3XPi Same as XF3 pXF3XPi This study
 XF3X01 Same as XF3 pXF3X01 This study
 XF3X02 Same as XF3 pXF3X02 This study
 XF3X03 Same as XF3 pXF3X03 This study
 XF3X04 Same as XF3 pXF3X04 This study
 XF3X05 Same as XF3 pXF3X05 This study
 XF3X06 Same as XF3 pXF3X06 This study
 XF3X07 Same as XF3 pXF3X07 This study
 XF3X08 Same as XF3 pXF3X08 This study
 XF3X09 Same as XF3 pXF3X09 This study
 XF3X10 Same as XF3 pXF3X10 This study
 XF3X11 Same as XF3 pXF3X11 This study
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with forward primer (XF_FP_csXR_ADH1t) and reverse 
primer (XF_RP_csXR_ADH1t); the ctXDH was ampli-
fied with forward primer (XF_FP_ TEF1p _CYC1t) and 
reverse primer (XF_RP_ctXDH_CYC1t); the ppXKS was 
amplified with forward primer (XF_FP_ppXKS_ADH2t) 
and reverse primer (XF_FP_ppXKS_ADH2t). The result-
ing PCR fragments have a 40  bp region homologous to 
constitutive yeast promoters and terminators, respec-
tively. The constitutive yeast PDC1p promoters with dif-
ferent strengths for csXR were amplified with forward 
primer (XF_FP_PDC1p) and reverse primer (XF_RP_
PDC1p) and using mutant PDC1p templates [28]. The 
different versions of TEF1p promoters for ctXDH and 
ENO2p promoters for ppXKS were achieved using the 
same methods. The DNA Assembler method was next 
used to construct the xylose utilization plasmids pRS416-
PDC1p (L/M/H)-csXR-ADH1t-TEF1p(L/M/H)-ctXDH-
CYC1t-ENO2p(L/M/H)-ppXKS-ADH2t with the proper 
combinations of each fragment (Fig. 1b). The sequences 
of all mutated promoters were listed in Additional file 1: 
Table S2.
Determination of 1‑hexadecanol production
The 1-hexadecanol was detected using a method previ-
ously described [3]. In general, for screening the 1-hexa-
decanol production in different strains, the engineered 
yeast strains were pre-cultured in 3  mL SC medium 
including all the appropriate nucleotides and amino 
acids, with 2  % glucose for 3  days until saturation. The 
cells were then centrifuged and washed twice with dou-
ble-distilled water. The cell pellets were next inoculated 
into 5 mL fresh SC medium with 40 g/L xylose in dispos-
able glass tubes overlaid with 10 % dodecane to prevent 
the evaporation of fatty alcohols and enrich the fatty 
alcohol in the organic layer to ease the measurement [3]. 
The concentrations of 1-hexadecanol were quantified at 
48 h [3]. The glass tubes of yeast cultures were allowed to 
sit for 2 min until the organic layer could be clearly visu-
alized. Then, 3 μL of dodecane was withdrawn from the 
organic layer and diluted by 100 times using ethyl acetate 
and analyzed by GC–MS (ShimadzuGC-MS-QP2010) 
with a DB-Wax column with 0.25  μm film thickness, 
0.25  mm diameter, and 30  m length (Agilent Inc., Palo 
Alto, CA). Tridecane at a concentration of 2  mg/L was 
used as the internal standard. The GC program was as 
follows: an initial temperature of 50  °C was maintained 
for 1.5  min, followed by ramping to 180  °C at a rate of 
25 °C/min. The temperature was then ramped to 250 °C 
at a rate of 10  °C/min, where the temperature was held 
for 3 min.
Evolutionary engineering
To improve xylose utilization of the engineered strain, 
the optimized strain was cultured and serial-transferred 
into 50 mL of fresh SC medium with 40 g/L xylose as the 
sole carbon source in a closed 100  mL flask. The cells 
were grown until the early stationary phase (~3  days) 
and spread on SC-xylose plates. After 3-days growth, 
the biggest colony was inoculated into a fresh medium 
and grown until the early stationary phase. Then the 
cells were sub-cultured with 5  % inoculums in biologi-
cal triplicates into fresh medium for the second round 
* Mutated promoters used for ethanol production [40]
Table 1 continued
Name Genotype Plasmids Reference
 XF3X12 Same as XF3 pXF3X12 This study
 XF3X13 Same as XF3 pXF3X13 This study
 XF3X14 Same as XF3 pXF3X14 This study
 XF3X15 Same as XF3 pXF3X15 This study
 XF3X16 Same as XF3 pXF3X16 This study
 XF3X17 Same as XF3 pXF3X17 This study
 XF3X18 Same as XF3 pXF3X18 This study
 XF3X19 Same as XF3 pXF3X19 This study
 XF3X20 Same as XF3 pXF3X20 This study
 XF3X21 Same as XF3 pXF3X21 This study
 XF3X22 Same as XF3 pXF3X22 This study
 XF3X23 Same as XF3 pXF3X23 This study
 XF3X24 Same as XF3 pXF3X24 This study
 XF3X25 Same as XF3 pXF3X25 This study
 XF3X26 Same as XF3 pXF3X26 This study
 XF3X27 Same as XF3 pXF3X27 This study
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evolutionary engineering using the SC medium with 
40 g/L xylose. The cells were grown for 3 days with typi-
cal OD600 in the range of 1.5–2.5. For each round of 
cell culture, the cell growth rate and fatty alcohol titer 
were measured using the method described above. We 
checked the plasmids intactness for each generation of 
the evolved strains by colony PCR, amplifying the cas-
settes for each gene, and confirming the intactness by 
DNA electrophoresis. All the plasmids were found to be 
intact (Additional file 1: Figure S1).
Fig. 1 Overview of the approaches for xylose-based fatty alcohol production and improvement. a Scheme for the introduction of xylose utilization 
pathway to a fatty alcohol-producing S. cerevisiae strain. The xylose utilization pathway was constituted with three fungal enzymes, XR, XDH and 
XKS, from our previous study. This pathway has been confirmed to use xylose as the sole carbon source. The XF3 strain was selected from our previ-
ous study in which we over-expressed a bird FAR to produce the 1-hexdecanol and engineered the yeast lipid metabolism to further improve the 
fatty alcohol production. b Plasmid design for promoter engineering to further improve the xylose-based fatty alcohol production. We designed 27 
different plasmids to exhaust all of the combinations of the promoters in front of XR, XDH, and XKS whose strengths were low, medium and high, 
respectively. The fatty alcohol production and growth behavior were monitored in these 27 recombinant strains
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Batch and fed‑batch fermentation
Both XF3XP and XF3XP07 yeast strains were first grown 
in 100  mL SC medium including all the appropriate 
nucleotides and amino acids, with 20  g/L glucose for 
2 days. Then, cells from 5 mL of culture were centrifuged, 
washed twice with double-distilled water, and inocu-
lated into 5 mL fresh SC medium with 40 g/L xylose in 
glass disposable tubes overlaid with 0.5  mL dodecane 
for batch fermentation. The initial ODs were similar, 
i.e., 2.38 ± 0.05 and 2.45 ± 0.06, with no significant dif-
ference (p  >  0.05). Samples were taken at various time 
points to measure the 1-hexadecanol concentration, 
OD600, and xylose concentration. At each time point, 
the glass tubes of yeast cultures were allowed to sit for 
2 min until the organic layer could be clearly visualized. 
To measure the 1-hexadecanol concentration, 3  μL of 
dodecane was withdrawn from the organic layer and then 
diluted by 100 times using ethyl acetate followed by the 
analysis using the GC–MS protocol mentioned above. 
To monitor OD600, 20  μL of yeast culture was taken 
from the water layer and mixed with 180 μL of double-
distilled water, followed by measuring the absorbance at 
600 nm using a Biotek Synergy 2 Multi-Mode Microplate 
Reader (Winooski, VT). To measure the concentration of 
xylose, 100 μL of yeast culture was taken from the water 
layer and mixed with 900  μL of double-distilled water, 
which was then centrifuged at 13,000 rpm for 5 min. The 
supernatant was taken and analyzed by Shimadzu HPLC 
(Columbia, MD) equipped with an Aminex HPX-87H 
column (Bio-Rad, Hercules, CA) and Shimadzu RID-10A 
refractive index detector. The column was kept at 50 °C, 
and 5  mM sulfuric acid solution was used as a mobile 
phase with a constant flow rate of 0.6 mL/min. Each data 
point represents the mean of triplicate samples. In this 
discontinuous fed-batch fermentation, additional xylose 
(0.5  mL with concentration of 200  g/L) and dodecane 
(0.05 mL) were fed every 12 h. Samples were taken after 
the replenishment to measure 1-hexadecanol concentra-
tion, OD600, and xylose concentration using the similar 
methods as that for batch fermentation. The biological 
triplicates were implemented in both batch and fed-batch 
fermentation for all the strains.
Results and discussion
Constructing a xylose utilization pathway in a fatty 
alcohol‑producing strain
In order to produce the xylose-based 1-hexadecanol, we 
first introduced the fungal xylose utilization pathway [29] 
into a 1-hexadecanol-producing S. cerevisiae strain, XF3 
[10] (Fig. 1). The xylose utilization pathway was selected 
from our previous study [29], which included a XR from 
Candida shehatae, a XDH from Candida tropicalis and 
a XKS from Pichia pastoris. The XF3 strain produced 
1-hexadecanol at over 1.1 g/L from glucose in S. cerevi-
siae as reported in our previous study [10]. The 1-hexade-
canol production in XF3 was achieved by heterologously 
expressing a FAR from barn owls, over-expressing acetyl-
CoA carboxylase (ACC1 gene), knocking out a negative 
regulator, RPD3 gene, in phospholipid synthesis, and 
over-expressing ATP-citrate lyases (ACL1 gene and 
ACL2 gene) from Yarrowia lipolytica to enhancing the 
supply of cytosolic acetyl-CoA (Fig.  1a). By introducing 
the fungal xylose utilization pathway into XF3 strain, we 
successfully generated a S. cerevisiae strain (XF3XP) to 
produce the 1-hexadecanol from xylose as the sole car-
bon source at 0.4  g/L (Table  2). The xylose-based fatty 
alcohol titer was lower than the glucose-based 1-hexade-
canol titer [10] and only 15 g/L xylose was consumed to 
produce 1-hexadecanol, indicating the xylose utilization 
could be a rate-limiting step for fatty alcohol produc-
tion. We also introduced another fungal xylose path-
way in which the promoter strengths of XR, XDH, and 
XKS were previously optimized to increase xylose-based 
ethanol production (XF3XPi, Table  2). We found that 
although 1-hexadecanol production could be increased 
to 0.48  g/L, the xylose utilization was even worse than 
the wild-type pathway with less than 5  g/L xylose con-
sumed. This is possibly due to the fact that the regulatory 
mechanism adopted by S. cerevisiae to control xylose-
based fatty alcohol production was different from that to 
control xylose-based ethanol production. Therefore, the 
metabolic engineering of S. cerevisiae for biofuel produc-
tion is target-specific.
Promoter engineering to improve 1‑hexadecanol 
production from xylose
In order to further improve the 1-hexadecanol produc-
tion, we implemented a synthetic biology approach 
called Customized Optimization of Metabolic Pathways 
by Combinatorial Transcriptional Engineering (COM-
PACTER) [28] to precisely control the gene expres-
sion levels of XR, XDH, and XKS. Basically, we chose 
three constitutive promoters, PPDC1, PTEF1, and PENO2 
to express XR, XDH and XKS genes, respectively. For 
each of the constitutive promoters, we mutated the 











XF3XP 14.9 ± 0.3 0.093 ± 0.009 0.40 ± 0.10 1.41 ± 0.32
XF3XPi 4.5 ± 0.4 0.096 ± 0.010 0.48 ± 0.09 0.48 ± 0.07
XF3XP07 7.8 ± 1.3 0.073 ± 0.007 0.79 ± 0.10 0.00 ± 0.00
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original promoters to create a promoter library with var-
ying strengths. We then selected promoters with high, 
medium, and low strengths (Additional file 1: Figure S2) 
for PPDC1, PTEF1, and PENO2, respectively, and constructed 
totally 27 synthetic xylose pathways (3 × 3 × 3 = 27) in 
S. cerevisiae with all of the promoter combinations of 
PPDC1, PTEF1, and PENO2 with different strengths (Fig. 1b; 
Table 1). We next compared the growth rates and 1-hexa-
decanol titers of all the recombinant S. cerevisiae strains 
to that of the control strains, XF3XP (Fig. 2). It is worth 
noticing that the purpose of combinatorial promoter 
screening was to find the strain with the highest fatty 
alcohol production from xylose instead of the best xylose 
utilization strain. Therefore, we did not measure the 
xylose utilization rates here. We found that the growth 
rates of most of the promoter-engineered strains were 
reduced to some extent, and the 1-hexadecanol produc-
tion for most of the recombinant strains was not signifi-
cantly improved. However, strain XF3X07 and XF3X25 
produced 1-hexadecanol at 171 and 140  % higher than 
that of the control strains with a slightly deceased growth 
rates (0.073 h−1 and 0.080 h−1) compared with the growth 
rate of the control strain (0.093 h−1). Both XF3X07 and 
XF3X25 used a high-level TEF1 promoter to express 
XDH and a low-level ENO2 promoter to express XKS. 
Nevertheless, XF3X07 used a low-level PDC1 promoter 
to express XR while XF3X25 used a high-level PDC1 pro-
moter. This discovery is consistent with previous studies 
showing that the XDH enzymes were rate-limiting steps 
in converting xylose to biomass and ethanol [30, 31]. 
Interestingly, despite of higher titer of 1-hexadecanol in 
XF3X07 compared to XF3XPi, the xylose-based 1-hexa-
decanol yields were similar in XF3XP07 and XF3XPi 
(p > 0.1). This indicated that the combinatorial promoter 
engineering mainly improved the xylose uptake rate 
instead of optimizing the host pathways to improve the 
conversion of xylose to 1-hexadecanol.
We correlated the strengths of promoters for XR, XDH, 
and XKS with the two measured parameters, 1-hexa-
decanol concentrations and growth rates (Additional 
file  1: Figure S3). No correlation was observed between 
promoter strengths and 1-hexadecanol concentrations. 
Neither did we find the correlation between promoter 
strengths and growth rates. We also correlated 1-hexa-
decanol concentrations and growth rates, but found no 













































































































Fig. 2 1-Hexadecanol produced and growth rates of engineered S. cerevisiae strains via promoter engineering. All the strains were cultured in the 
SC-xylose (4 %) medium for 48 h. The bars with lighter color were the values for the control strain (i.e., XF3XP) with the xylose utilization pathway 
using the native promoters
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S4). Therefore, it is unfeasible to solely use the results of 
promoter screening to make predictions on the choice of 
promoters that should be used for xylose-based produc-
tion of 1-hexadecanol. This is because the introduction 
of xylose pathways would trigger the global metabolic 
rewiring, as we found previously when investigating met-
abolic responses to different xylose utilization pathways 
via 13C metabolic flux analysis [32]. This global metabolic 
rewiring involves the reprogramming of not only xylose 
pathway itself but also the downstream pathways, which 
made the xylose metabolism too complex to be corre-
lated with the activity of xylose utilization pathway itself.
Evolutionary engineering to improve 1‑hexadecanol 
production from xylose
We next chose XF3X07 and XF3X25 as our target strains 
for further evolutionary engineering to improve the 
1-hexadecanol production. Evolutionary engineering has 
been widely used to improve the pentose utilization and 
xylose-based ethanol production in S. cerevisiae success-
fully [33–35]. Considering the poor xylose uptake in our 
engineered strains, we implemented the evolutionary 
engineering to investigate whether fatty alcohol produc-
tion is growth-associated, and if so, to further improve 
the xylose-based fatty alcohol production. Similar as the 
study of combinatorial promoter screening, our goal of 
evolutionary engineering is to seek a yeast strain that 
could produce fatty alcohols from xylose as much as pos-
sible. Therefore, we did not measure the xylose utilization 
rates. In general, we serially transfer the strain XF3X07 
and XF3X25 to synthetic medium with 40  g/L xylose 
twice. Namely, the optimized strain was the second gen-
eration evolved from the wild-type strain. We found 
that the growth rates of two strains increased gradually 
(~25 and ~ 35 %) for every round as expected. However, 
such increase was associated with reduced 1-hexade-
canol production. For example, the highest growth rate 
was reached for both XF3X07 and XF3X25 with the low-
est titer of 1-hexadecanol in the second round (Fig.  3). 
The growth rates of the evolved strains in the last round 
were significantly increased for XF3XP07 and XF3XP25 
(p < 0.05). However, the 1-hexadecanol productions were 
not significantly changed (p  >  0.05). Such discrepancy 
indicated that 1-hexadecanol, unlike ethanol, was not a 
growth-associated product. Since evolutionary engineer-
ing selects the mutant strain with higher growth rate, the 
1-hexadecanol production failed to be further improved 
via adaptive evolution due to the de-coupling between 
the cell growth rate and the fatty alcohol production. In 
addition, we applied flux balance analysis to calculate 
the ATP, NADH, and NADPH synthesis under differ-
ent 1-hexadecanol productions (Additional file 1: Figure 
S5). We found that the NADPH and ATP synthesis were 
positively correlated with 1-hexadecanol production, 
while NADH synthesis did not change too much with the 
1-hexadecanol synthesis. Overall, the evolutionary engi-
neering approach would be helpful to improve the cell 
growth and growth-associated products such as ethanol, 
but not for non-growth associated products such as fatty 
acid-derived chemicals.
Batch and fed‑batch fermentation for 1‑hexadecanol 
production
With XF3XP07 as our best strain to produce xylose-based 
1-hexadecanol, we next characterized its 1-hexadecanol 
production using batch and fed-batch fermentation. 
In batch fermentation, we found that 0.79  g/L 1-hexa-
decanol was produced from 7.8  g/L xylose, with a cell 
growth rate at 0.073  h−1 (Table  2). This 1-hexadecanol 
titer of XF3XP07 is significantly higher than the ones of 
Fig. 3 Evolutionary engineering of XF3X07 and XF3X25. 1-hexadecanol production (a) and growth rates (b) of the XF3X07 and XF3X25 in each 
round were normalized with 1-hexadecanol titer and growth rates of the XF3X07 and XF3X25 in round zero, respectively
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XF3XP and XF3XPi strain (p < 0.05). More interestingly, 
comparing the xylose uptakes of the XF3XP and XF3XPi, 
we found the XF3XP strain consumed three-fold more 
xylose than the XF3XPi strain. This additional xylose was 
mainly used to produce more ethanol in XF3XP strains 
(Table 2). In addition, we have measured the accumula-
tion of intracellular 1-hexadecanol, which was less than 
5  % of the extracellular concentration of 1-hexadecanol 
from the organic layer. Such low accumulation is consist-
ent with several previous studies when yeast was cultured 
with an organic layer [36], although it is also reported 
that S. cerevisiae strains could accumulate a large amount 
of fatty alcohols intracellularly when cultured without the 
organic layer [37].
In fed-batch fermentation, we used resting cells for fer-
mentation, i.e., the cell density was kept at high level to 
prevent using the xylose to produce biomass. Although 
the fermentation at high cell density might limit the 
oxygen supply for the fermentation, which is an impor-
tant factor for the optimal expression of the xylose path-
way genes [38], the marginal net growth rate of yeast 
cells could be more important in fed-batch fermentation 
because it was found in this study that fatty alcohol pro-
duction was not growth-associated and hence by remov-
ing the biomass production, yeast cells could serve as 
biocatalysts to convert xylose to 1-hexadecanol with high 
efficiency. We found that a long lag phase lasting around 
40 h in the fed-batch fermentation, which could be due to 
the repression of residue glucose from the inoculum since 
we cultured XF3XP and XF3XP07 with 20  g/L glucose 
before transferring the cells into the medium with xylose, 
and hence cells needed a long time to accustom to xylose 
from glucose (Fig.  4). For the XF3XP strain, 1-hexade-
canol has been produced quickly with a low xylose con-
sumption, and achieved ~0.6 g/L of 1-hexadecanol at 48 h 
(Fig. 4a). For the XP3XP07 strain, after the long lag phase, 
1-hexadecanol was produced rapidly with the increased 
xylose uptake and reached the highest titer of 1-hexade-
canol at 1.2 g/L at the 69 h (Fig. 4b). However, when con-
tinuing the fed-batch fermentation for both strains, both 
the 1-hexadecanol concentrations and xylose uptake rates 
were decreased. The observed low xylose consumption 
rate accompanied with the decrease of OD600 suggested 
a starvation because of the incapability to further uptake 
the carbon substrate and the probable limitation by other 
nutrients such as nitrogen and phosphate after the 50  h 
of the fermentation. In our previous study [10], we found 
that fatty alcohols could be taken up by S. cerevisiae, 
which could be the reason for the decreased fatty alcohol 
production when xylose utilization became limited.
Comparing the xylose-based fatty alcohol production 
to the glucose-based one in the previous study, the simi-
lar titer of fatty alcohol from fed-batch fermentation has 
been observed, demonstrating the successful integration 
of xylose utilization pathway and the fatty alcohol pro-
duction pathway. However, the yields of xylose-based 
fatty alcohols in both batch (0.10  ±  0.02  g/g) and fed-
batch fermentation (0.08 ±  0.01  g/g) were much higher 
than that of glucose-based ones (~0.03 and <0.01  g/g), 
respectively. The theoretical maximum yields through 
this production pathway from xylose and glucose were 
~0.34 and ~0.35 (g/g), respectively. In this case, the yield 
from xylose reached nearly one-third of the theoreti-
cal yield, while the yield from glucose only reached less 
than 10  % of the theoretical yield. The bypass of etha-
nol production when feeding xylose instead of glucose 
likely attributed to the high yield of xylose-based 1-hex-
adecanol, which could divert more carbons to be uti-
lized in the fatty alcohol production rather than ethanol 
production.
Fig. 4 Fed-batch fermentation of xylose-based 1-hexadecanol production by a XF3XP and b XF3XP07. Ethanol was detected as the only byproduct 
other than 1-hexadecanol. Black square the 1-hexadecanol concentration; blue triangle the xylose consumed; red dot OD600
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Conclusion
A fatty alcohol-producing S. cerevisiae strain was engi-
neered in this study to produce 1-hexadecanol from 
xylose. To achieve this, a xylose utilization pathway 
consisting of XR, XDH and XK was heterologously 
expressed in S. cerevisiae, followed by optimization of 
the xylose-based fatty alcohol production through pro-
moter engineering and evolutionary engineering to 
improve 1-hexadecanol production by 171  %. Through 
fed-batch fermentation, the highest titer of 1-hexade-
canol reached 1.2  g/L with xylose used as the sole car-
bon source. Although the xylose pathway we developed 
in this study was still not optimal, this proof-of-concept 
study, for the first time to our best knowledge, indicated 
that the xylose-based fatty alcohol could be achieved in S. 
cerevisiae with potential applications in developing con-
solidated bioprocessing for producing fatty acid-derived 
chemicals.
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